Authors: ROBERTS TC BRENNAN DC BULLER RS GAUDREAULTKEENER M SCHNITZLER MA STERNHELL KE GARLOCK KA SINGER GG STORCH GA

Citation: Tc. Roberts et al., QUANTITATIVE POLYMERASE-CHAIN-REACTION TO PREDICT OCCURRENCE OF SYMPTOMATIC CYTOMEGALOVIRUS-INFECTION AND ASSESS RESPONSE TO GANCICLOVIR THERAPY IN RENAL-TRANSPLANT RECIPIENTS, The Journal of infectious diseases, 178(3), 1998, pp. 626-635

Authors: BRENNAN DC GARLOCK KA LIPPMANN BA BULLER RS GAUDREAULTKEENER M LOWELL JA MILLER SB SHENOY S HOWARD TK STORCH GA

Citation: Dc. Brennan et al., CONTROL OF CYTOMEGALOVIRUS-ASSOCIATED MORBIDITY IN RENAL-TRANSPLANT PATIENTS USING INTENSIVE MONITORING AND EITHER PREEMPTIVE OR DEFERRED THERAPY, Journal of the American Society of Nephrology, 8(1), 1997, pp. 118-125

Authors: BRENNAN DC GARLOCK KA LIPPMANN BJ BULLER RS GAUDREAULTKEENER M LOWELL JA MILLER SB SHENOY S HOWARD TK STORCH GA

Citation: Dc. Brennan et al., POLYMERASE CHAIN REACTION-TRIGGERED PREEMPTIVE OR DEFERRED THERAPY TOCONTROL CYTOMEGALOVIRUS-ASSOCIATED MORBIDITY AND COSTS IN RENAL-TRANSPLANT PATIENTS, Transplantation proceedings, 29(1-2), 1997, pp. 809-811

Authors: BRENNAN DC GARLOCK KA SINGER GG SCHNITZLER MA LIPPMANN BJ BULLER RS GAUDREAULTKEENER M LOWELL JA SHENOY S HOWARD TK STORCH GA

Citation: Dc. Brennan et al., PROPHYLACTIC ORAL GANCICLOVIR COMPARED WITH DEFERRED THERAPY FOR CONTROL OF CYTOMEGALOVIRUS IN RENAL-TRANSPLANT RECIPIENTS, Transplantation, 64(12), 1997, pp. 1843-1846